Why Do Some Recovered Peripartum Cardiomyopathy Mothers Experience Heart Failure With a Subsequent Pregnancy?

被引:17
|
作者
Fett J.D. [1 ,2 ,4 ]
Shah T.P. [3 ]
McNamara D.M. [1 ]
机构
[1] Investigations of Pregnancy Associated Cardiomyopathy (IPAC), Peripartum Cardiomyopathy Network of North America (PCN), Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA
[2] Department of Adult Medicine, Hospital Albert Schweitzer, Deschapelles
[3] Baylor College of Medicine, Houston, TX
[4] 2331 Mt. Hood Court SE, Lacey, 98503, WA
关键词
Biomarkers; Echocardiography; Heart failure; Outcomes; Peripartum cardiomyopathy; PPCM; Subsequent pregnancy;
D O I
10.1007/s11936-014-0354-x
中图分类号
学科分类号
摘要
After concerns about survival and recovery from peripartum cardiomyopathy (PPCM), the question commonly asked is, “Is it safe to have another pregnancy?” While important advances have been made in the past decade in the recognition and treatment of PPCM, we still do not know why some apparently recovered PPCM mothers have a relapse of heart failure in a subsequent pregnancy. Knowing that some risk for relapse is always present, careful monitoring of the post-PPCM pregnancy is currently the best way to enable earlier diagnosis with institution of effective evidence-based treatment. In that situation it is reassuring to observe that when a subsequent pregnancy begins with recovered left ventricular systolic function to echocardiographic ejection fraction ≥0.50, even with relapse, the response to treatment is good with much more favorable outcomes. On the other hand, beginning the subsequent pregnancy with echocardiographic ejection fraction <0.50 greatly increases the risk for less favorable outcomes. This article summarizes the current state of knowledge; addresses the important questions facing patients, their families, and caregivers; and identifies the need for a prospective multi-center study of women with post-PPCM pregnancies. The reality is that an estimated 10 % to 20 % of apparently recovered PPCM mothers are going to relapse in a post-PPCM pregnancy; but we do not yet know why. Nevertheless, the lowest risk for relapse is experienced by those who (1) recover to left ventricular ejection fraction 0.55 prior to another pregnancy; (2) have no deterioration of left ventricular ejection fraction after phasing out angiotensin-converting enzyme inhibitor/angiotensin-receptor blocker treatment following recovery; and perhaps, (3) demonstrate adequate contractile reserve on exercise echocardiography. © 2014, Springer Science+Business Media New York.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Peripartum cardiomyopathy: A case report of decompensated heart failure in a hypertensive patient
    Elendu, Chukwuka
    Okoye, Osinachi K.
    MEDICINE, 2024, 103 (13) : E37600
  • [32] Withdrawal of heart failure medications in peripartum cardiomyopathy after myocardial recovery
    Tahir, Usman
    Sama, Flora
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 190 : 212 - 213
  • [33] The association of heart rate with adverse outcomes and recurrent heart failure hospitalization in peripartum cardiomyopathy
    Berkowitz, Julia
    Sagaityte, Emilija
    Khalid, Mahnoor
    Lopez, Diana
    Mohebali, Donya
    Bello, Natalie
    Arany, Zoltan
    French, Katharine
    Poppas, Athena
    Sabe, Marwa
    Wu, Wen-Chih
    Joseph, Jacob
    Djousse, Luc
    Choudhary, Gaurav
    Imran, Tasnim F.
    CLINICAL RESEARCH IN CARDIOLOGY, 2025,
  • [34] Cabergoline as an adjuvant to standard heart failure treatment in peripartum cardiomyopathy: A case report and review of the literature
    Caruso, Giuseppe
    Scopelliti, Annalisa
    Scaramuzzino, Sara
    Perrone, Giuseppina
    Galoppi, Paola
    Palaia, Innocenza
    Muzii, Ludovico
    Panici, Pierluigi Benedetti
    Brunelli, Roberto
    CASE REPORTS IN WOMENS HEALTH, 2021, 29
  • [35] Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy
    Nonhoff, Justus
    Ricke-Hoch, Melanie
    Mueller, Mirco
    Stapel, Britta
    Pfeffer, Tobias
    Kasten, Martina
    Scherr, Michaela
    von Kaisenberg, Constantin
    Bauersachs, Johann
    Haghikia, Arash
    Hilfiker-Kleiner, Denise
    CARDIOVASCULAR RESEARCH, 2017, 113 (06) : 598 - 608
  • [36] Epidemiology of “Heart Failure with Recovered Ejection Fraction”: What do we do After Recovery?
    Kuttab J.S.
    Kiernan M.S.
    Vest A.R.
    Current Heart Failure Reports, 2015, 12 (6) : 360 - 366
  • [37] Frequency and Clinical Implications of Referrals to Heart Failure Among Patients with Peripartum Cardiomyopathy
    Qureshi, Brief Report Natasha
    Kontorovich, Amy
    Veledar, Emir
    Tlachi, Pilar
    Feltovich, Helen
    Mancini, Donna M.
    Barghash, Maya
    Stone, Joanne
    Bianco, Angela
    Shaw, Leslee J.
    Lala, Anuradha
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (05) : 717 - 721
  • [38] Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
    Sliwa, Karen
    Hilfiker-Kleiner, Denise
    Petrie, Mark C.
    Mebazaa, Alexandre
    Pieske, Burkert
    Buchmann, Eckhart
    Regitz-Zagrosek, Vera
    Schaufelberger, Maria
    Tavazzi, Luigi
    van Veldhuisen, Dirk J.
    Watkins, Hugh
    Shah, Ajay J.
    Seferovic, Petar M.
    Elkayam, Uri
    Pankuweit, Sabine
    Papp, Zoltan
    Mouquet, Frederic
    McMurray, John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (08) : 767 - 778
  • [39] SUCCESSFUL PREGNANCY, DELIVERY AND PUERPERIUM IN A HEART-TRANSPLANT PATIENT WITH PREVIOUS PERIPARTUM CARDIOMYOPATHY
    CARVALHO, AC
    ALMEIDA, D
    COHEN, M
    LIMA, V
    MOURA, L
    BUFFOLO, E
    MARTINEZ, EE
    EUROPEAN HEART JOURNAL, 1992, 13 (11) : 1589 - 1591
  • [40] Heart failure due to peripartum cardiomyopathy presenting in the first week of puerperium-A case series from Nepal
    Banmala, Sabin
    Awal, Shila
    Bata, Lokendra
    Adhikari, Priya
    Basnet, Sarita
    Chaudhary, Babita
    CLINICAL CASE REPORTS, 2024, 12 (06):